Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.67 |
| ▸ | FAAH | O00519 | 1/20 | 0.57 |
| ▸ | MGLL | Q99685 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 9/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27783156 | 0.87 | AKR1C3 (0.85) | AKR1C3FAAHMGLLMAPTALDH1A1 | |
| SCHEMBL15271096 | 0.81 | AKR1C3 (0.76) | AKR1C3FAAHMGLLMAPTALDH1A1 | |
| SCHEMBL24937862 | 0.80 | AKR1C3 (0.62) | AKR1C3FAAHMGLLMAPTALDH1A1 | |
| SCHEMBL5466738 | 0.80 | SIRT6 (0.79) | AKR1C3MAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL24937721 | 0.80 | AKR1C3 (0.63) | AKR1C3MAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL24937183 | 0.80 | AKR1C3 (0.65) | AKR1C3MAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL1393155 | 0.79 | AKR1C3 (0.68) | AKR1C3MAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL6151230 | 0.78 | SIRT6 (0.81) | AKR1C3MAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL15271381 | 0.78 | SIRT6 (0.81) | AKR1C3MAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL626155 | 0.78 | AKR1C3 (0.67) | AKR1C3MAPTALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230024778-A1 | STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND | THE UNIVERSITY OF TOKYO (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024778-A1 | STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND | UTS2R, TAS1R1, ULK3 | AKR1C3 689/4885FAAH 3853/4885MGLL 2443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.